Pacira BioSciences, Inc. (PCRX)

Accolade Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	300.48	276.77	153.3	104.14	585.58	99.96
Short-Term Investments	145.38	207.84	125.28	184.51	70.83	421.71
Cash & Short-Term Investments	445.86	484.62	278.58	288.65	656.41	521.66
Cash Growth	10.30%	73.96%	-3.49%	-56.03%	25.83%	78.68%
Accounts Receivable	114.37	113.3	105.56	98.4	96.32	53.05
Other Receivables	-	0.5	0.4	0.8	0.1	1.6
Receivables	114.37	113.8	105.96	99.2	96.42	54.65
Inventory	148.16	125.28	104.35	96.06	98.55	64.65
Prepaid Expenses	37.22	20.43	20.4	14.32	14.67	10.67
Other Current Assets	-	1	0.7	0.1	-	-
Total Current Assets	745.61	745.13	509.99	498.33	866.05	651.62
Property, Plant & Equipment	201.71	216.39	234.95	254.39	264.81	211.18
Long-Term Investments	18.81	29.45	32.26	60.18	21.99	109.48
Goodwill	20.3	-	163.24	163.24	145.18	99.55
Other Intangible Assets	422.56	425.97	483.26	540.55	623.97	96.52
Long-Term Deferred Tax Assets	128.27	130.38	144.49	160.31	153.36	106.16
Other Long-Term Assets	-	6.2	6.2	4.2	-	-
Total Assets	1,537	1,554	1,574	1,681	2,075	1,275
Accounts Payable	30.12	19.13	15.7	15.22	10.54	10.43
Accrued Expenses	71.02	69.52	55.72	82.49	118.6	68.78
Current Portion of Long-Term Debt	202.4	201.78	8.64	33.65	374.7	149.65
Current Portion of Leases	9.62	8.89	8.8	9.12	7.89	7.43
Current Income Taxes Payable	-	-	-	-	0.43	0.11
Other Current Liabilities	-	10.61	8.53	7.3	8.95	16.93
Total Current Liabilities	313.16	309.92	97.38	147.77	521.12	253.33
Long-Term Debt	378.1	383.55	513.8	655.82	674.53	313.03
Long-Term Leases	41.29	44.65	54.81	64.8	71.73	71.03
Other Long-Term Liabilities	42.36	37.06	38.27	37.79	77.57	17.44
Total Liabilities	779.5	775.17	704.26	906.19	1,345	654.83
Common Stock	0.05	0.05	0.05	0.05	0.05	0.04
Additional Paid-In Capital	1,036	1,009	976.63	924.1	942.09	873.2
Retained Earnings	-206.39	-206.36	-106.8	-148.75	-211.9	-253.88
Treasury Stock	-75.52	-25.12	-	-	-	-
Comprehensive Income & Other	4.06	0.34	0.25	-0.38	0.17	0.32
Shareholders' Equity	757.77	778.35	870.13	775.01	730.41	619.69
Total Liabilities & Equity	1,537	1,554	1,574	1,681	2,075	1,275
Total Debt	631.4	638.85	586.04	763.39	1,129	541.13
Net Cash (Debt)	-185.54	-154.24	-307.46	-474.74	-472.44	-19.47
Net Cash Per Share	-4.03	-3.34	-5.92	-10.20	-10.35	-0.45
Filing Date Shares Outstanding	44.93	46.28	46.5	45.95	44.85	43.86
Total Common Shares Outstanding	44.9	46.24	46.48	45.93	44.73	43.64
Working Capital	432.45	435.21	412.61	350.56	344.93	398.3
Book Value Per Share	16.88	16.83	18.72	16.87	16.33	14.20
Tangible Book Value	314.9	352.38	223.63	71.22	-38.74	423.62
Tangible Book Value Per Share	7.01	7.62	4.81	1.55	-0.87	9.71
Machinery	-	186.07	141.5	136.46	133.34	89.52
Construction In Progress	-	28	105.91	103.23	80.56	71.09
Leasehold Improvements	-	86.03	61.83	61.3	59.74	54.43

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q